Taipei, Taiwan

Hsuan-Ang Tsai

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Syneurx International (Taiwan) Corp.. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hsuan-Ang Tsai. Retrieved from https://idiyas.com/inventor/hsuan-ang-tsai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hsuan-Ang Tsai: Innovator in Neuropsychiatric and Tuberculosis Treatments

Introduction

Hsuan-Ang Tsai is a noteworthy inventor based in New Taipei, Taiwan. He has made significant contributions to the field of medicine through his innovative research and development of pharmaceutical compounds. His work primarily focuses on formulations used in treating neuropsychiatric disorders and tuberculosis.

Latest Patents

Hsuan-Ang Tsai holds a patent for "Formulations of cycloserine compounds and applications thereof". This patent details formulations that comprise cycloserine compounds combined with one or more enteric materials in solid dosage forms. The applications of this invention are profound, as they aim to treat and/or reduce the risk of neuropsychiatric disorders or tuberculosis.

Career Highlights

Tsai is currently employed at Syneurx International Corporation, where he plays a crucial role in advancing pharmaceutical formulations. His professional journey reflects a strong dedication to improving healthcare through innovative solutions.

Collaborations

Throughout his career, Hsuan-Ang Tsai has collaborated with colleagues such as Guochuan Emil Tsai and Ching-Cheng Wang. These partnerships have fostered an environment of innovation, leading to advancements in treatment methodologies and pharmaceutical applications.

Conclusion

Hsuan-Ang Tsai exemplifies the spirit of innovation in the pharmaceutical industry. His patent and collaborative efforts contribute significantly to the ongoing battle against neuropsychiatric disorders and tuberculosis. As an inventor, Tsai continues to pave the way for future developments in medical research and therapeutic innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…